Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome

Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome

Gonadotrophin releasing hormone agonist with low dose human chorionic gonadotrophin co-triggers versus gonadotrophin releasing hormone agonist alone for reducing the risk of ovari

Use of Gonadotropin-Releasing Hormone Agonists in Induction of Ovulation: Review Article

The outcomes of gonadotropins releasing hormone (GnRH) antagonist cycles with and without letrozole co-treatment in patients undergoing ICSI

Early Initiation of Gn RH Antagonist versus long agonist Protocols in PCOS Patients Undergoing ICSI Cycles.

Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome

THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS

The Effect of Dual Trigger of Oocyte Maturation with Gonadotropin-Releasing Hormone Agonist and Low-Dose Human Chorionic Gonadotropin on Pregnancy Rate in Women at Risk of Ovaria

Is Addition of GNRH Agonist to HRT Significant in Improving The Outcome in FTE Transfer Cycles : Randomized Study